Henry James International Management Inc. - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 155 filers reported holding ASCENDIS PHARMA A/S in Q3 2020. The put-call ratio across all filers is 0.38 and the average weighting 0.7%.

Quarter-by-quarter ownership
Henry James International Management Inc. ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q3 2023$2,293,712
+4.9%
24,4950.0%0.99%
+4.7%
Q2 2023$2,186,179
-21.6%
24,495
-5.9%
0.95%
-19.7%
Q1 2023$2,789,543
-12.2%
26,017
-0.0%
1.18%
-23.1%
Q4 2022$3,178,189
+18.3%
26,0230.0%1.54%
+2.5%
Q3 2022$2,687,000
+23.9%
26,023
+11.6%
1.50%
+38.1%
Q2 2022$2,168,000
-37.8%
23,322
-21.5%
1.08%
-21.1%
Q1 2022$3,488,000
-29.7%
29,722
-19.5%
1.38%
-10.1%
Q4 2021$4,964,000
-15.6%
36,8990.0%1.53%
-17.5%
Q3 2021$5,881,000
+25.8%
36,899
+3.8%
1.85%
+38.6%
Q2 2021$4,676,000
+2.3%
35,544
+0.2%
1.34%
-3.0%
Q1 2021$4,573,000
-29.3%
35,484
-8.5%
1.38%
-38.9%
Q4 2020$6,468,000
+8.1%
38,7830.0%2.26%
-7.7%
Q3 2020$5,985,000
+4.3%
38,783
+0.0%
2.44%
+1.8%
Q2 2020$5,736,000
+150.0%
38,782
+90.4%
2.40%
+103.8%
Q1 2020$2,294,000
+96.1%
20,369
+142.3%
1.18%
+159.5%
Q4 2019$1,170,000
-5.9%
8,407
-34.9%
0.45%
-14.3%
Q3 2019$1,243,000
+28.4%
12,907
+53.5%
0.53%
+27.7%
Q2 2019$968,000
+134.4%
8,407
+139.7%
0.42%
+121.9%
Q1 2019$413,0003,5070.19%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q3 2020
NameSharesValueWeighting ↓
RA Capital Management 5,865,338$978,221,00013.68%
Vivo Capital, LLC 1,797,745$299,828,00013.38%
Sofinnova Investments, Inc. 1,109,874$185,105,00011.02%
Avoro Capital Advisors LLC 1,800,000$300,204,0005.17%
Eventide Asset Management 1,704,148$284,218,0004.36%
Stenahm Asset Managment Ltd 29,000$4,837,0004.07%
Ghost Tree Capital, LLC 105,000$17,512,0003.90%
Eversept Partners, LP 187,043$31,195,0323.66%
Spyglass Capital Management LLC 701,594$117,012,0003.59%
Q Global Advisors, LLC 23,183$3,866,0002.72%
View complete list of ASCENDIS PHARMA A/S shareholders